The class II antigens ofthe human MHC are cell surface heterodimers composed of noncovalently linked 35-kD a chains and 29-kD (3 chains . These antigens are present on macrophages, B lymphocytes, and other APC (for review, see reference 1). Class II antigens are capable of binding immunogenic peptides and thereby serve as ligand for the TCR (2, 3). Recent experiments have demonstrated that class II proteins are also functional ligands for the T cell surface antigen CD4 (4-6).
is concentrated in three regions located in the NHz-terminal half of the molecule, termed the 01 domain. Extensive allelic variability is also located in the first domain of the DQa, DQ3, and DPS chains (7, 8) .
A third form of diversity is possible if the a chain of one isotype pairs with the (3 chain of another, creating a so-called mixed isotypic pair. Such pairings have not been demonstrated on APC in vivo using available monoclonal and polyclonal serological reagents . The pair DRa/DQ3 has been found in particular transformed B cell lines that express high levels of the DR a chain (9) . Modulation of the level of expression of DR a chains in B cell lines controlled the formation of the DRa/DQ8 pair, in that only cells expressing high levels of DRa mRNA produced this mixed isotypic pair (10) . Cell surface expression of mixed isotypic pairs was detected in cells transfected with different combinations of a and 0 chains, presumably because high levels of mRNA for each chain were produced in those cells (11) .
STRUCTURAL REQUIREMENTS FOR CLASS II a/0 CHAIN PAIRING
The murine counterpart of the DRa/DQf3 pair, namely Ea/A/3, was expressed at the surface of transfected cells (12, 13) , and was detected biochemically on a particular B cell lymphoma (14) . Only the A/3 chain from the H-2d haplotype was able to pair with the Eat chain, and this permissive pairing was controlled by the first 50 amino acids of the A/3 chain (15) . Expression of the mixed isotypic pair Ea/A(3 in cells cotransfected with isotypically matched chains occurred only ifthe mismatched chain was present in excess, suggesting an inefficient assembly of the mixed isotypic pair (16) . It is not known whether the nonpermissive combinations ofmixed isotypic pairs fail to be expressed because they do not assemble intracellularly, or because of a defect in transport to the cell surface .
In this report, we present the development of an efficient transient transfection system for the expression of mutated human class II cDNA molecules . It was possible to demonstrate the presence ofDR and DP antigens both by cell surface staining and by metabolic labeling. Mixed isotypic pairs did not assemble efficiently and were not detected at the cell surface . Using a series ofchimeric (3 chain cDNAs containing DR and DP sequences transfected into cells expressing either the DR or DP a chain, regions ofS sequence that are important for isotypic pairing were identified. These regions are different for DR and DP, and suggest that there are important constraints on secondary and tertiary structure that determine the ability of a given a chain to form a stable heterodimer.
Materials and Methods
Tissue Culture. The murine fibroblastic cell line DAP-3 (17) was used throughout the experiments. Cells were maintained in DME, high glucose formulation (Hazleton Biologics, Inc., Lenexa, KS), supplemented with 10% heat-inactivated FCS, 2 mM glutamine, 1 mM sodium pyruvate, 10 mM Hepes buffer, pH 7.4, and 10 lAg/ml gentamicin. Medium for the selection of cells transfected with the bacterial gpt gene (see below) consisted of DME supplemented as above plus mycophenolic acid (6,ug/ml), xanthine (0.25 mg/ml), and hypoxanthine (15 lAg/ml) (MXH)' (18) .
Antibodies. The following mAbs were used: SG465, anti-human class II (19); SG520, anti-DR,DPS chain (20) ; SG171, anti-DR,DP /3 chain (21) (generously provided by Dr. S. Goyert, Cornell University Medical College) ; 1135, anti-DR a chain (provided by Dr. J. Bodmer ICRF, London) (22) ; and P4H5, a hamster mAb to murine invariant chain (Dr. S. Cullen, personal communication) . Rabbit antisera to synthetic peptides corresponding to the COOH termini of DR or DP fl chains were prepared as described (23) . Briefly, synthetic peptides were prepared corresponding to the COOH-terminal 10 and 11 residues of the DR1 or DP2 /3 chains, respectively. These peptides were coupled to keyhole limpet hemocyanin via an additional NH2-terminal cysteine residue . The peptide-carrier conjugate (2001.ag) was mixed with CFA and injected subcutaneously. The rabbits were boosted at 2, 3, and 13 wk by the injection of an additional 200 Kg of antigen in IFA . Sera were obtained 2 wk after the last injection and tested by antipeptide ELISA.
Stable Transfections. DAP-3 cells (5 x 105/100-mm dish) were transfected using the calcium phosphate coprecipitation technique (24) . 15 p,g of the recombinant plasmids RSV5 DRa or RSV.5 DPa were used for each transfection. These plasmids contain both the class II cDNA under the control of the Rous sarcoma virus long terminal repeat (RSV LTR), as well as theEscherichia coli guanyl phosphoribosyl transferase gene under the control ofthe SV40 early promoter. Their construction will be described elsewhere . 2 d after transfection, the cells were placed into MXH-containing medium. Surviving cells were cloned by limiting dilution. Individual clones were tested for expression of the a chain cDNA either by mRNA determination, or by the expression ofdimeric class II molecules after transient transfection of class 11 0 chains (see below) .
Construction ofa Replicating cDNA Expression Vectorfor Murine Cells. The eukaryotic expression vector RSV3 contains the RSV LTR, a multiple cloning site from pUC12, and SV40-derived polyadenylation sequences plus pBR322 sequences for bacterial replication and ampicillin resistance (25) . To facilitate later cloning, this vector was digested at the unique Hind III site at the Tend of the small polylinker region, repaired with Klenow, and a Cla I linker was added. The resultant plasmid was then linearized at the Bam HI site at the 3' end of the SV40 termination sequences. This DNA was ligated to a 3.6-kb fragment derived by digesting the plasmid pSV5-neo with Bam HI (26) . This fragment contains the entire polyoma virus early region, including the origin of replication and genes for the small, middle, and large T antigens. The resultant plasmid, termed R3CPy-II (Fig. 1) , contains two unique sites for cDNA insertion: Cla I and Sal I. For most of the class II constructs (see below) this vector was digested with both of these enzymes to allow directed cloning.
Generation ofMutant and Chimeric Class 11, 8 Chains. Inspection of the cDNA sequences for the DRl and DP2 a chains (27) revealed several positions where either a unique restriction site already existed at the same place in each cDNA, or could be created by one or two point mutations (Fig . 2) . The mutations required to accomplish this are given in Table I . First, the cDNAs for the DRl and DP2,6 chains were removed from the original cloning vector (27) with the enzymes Sma I and Bam HI, and the Barn HI site was filled in with Klenow enzyme . The cDNAs were then cloned into a Klenow-repaired Sal I site in the vector Bluescript SK(-) (Stratagene, La Jolla, CA). Recombinant plasmids were analyzed for the orientation of the insert, and clones with the Tend of the cDNA nearest the Cla I site of the vector were identified . The cDNA with the vector-derived flanking Cla I and Xho I sites was removed with the enzymes Eco RI and Kpn I, and inserted into replicative form of M13 mpl9 digested with the same enzymes. Mutagenesis was performed on these recombinant phages using the Mutagene Kit (BioRad Laboratories, Richmond, CA) as directed by the supplier. Synthetic oligonucleotide primers for the mutagenesis were 36 mers produced on a DNA synthesizer (38013 ; Applied Biosystems, Inc., Foster City, CA) and purified by PAGE. The presence of the desired mutations was determined by DNA sequencing using the chain termination method (28) . Efficiency o£ the mutagenesis was typically 75-100%.
Replicative form DNA was generated from M13 clones with verified mutations. This was digested with Cla I and Xho 1, and the resultant mutant class II cDNA was isolated from a low melting point agarose gel. This insert was then cloned into either the expression vector for functional analysis or Bluescript for further manipulation .
Chimeric 0 chain cDNAs were generated by digesting the wild-type or mutant class II chain cDNA cloned into Bluescript with either Cla I or Xho I and the restriction endonuclease R3CPy-II, a polyoma-based eukaryotic expression vector. A vector for transient expression of cDNAs was constructed by ligation of a DNA segment containing the polyoma virus early region into the expression vector RSV.3 containing the ampicillin resistance gene, the bacterial origin of replication, the RSV LTR, and the SV40 poly(A) addition sequences (AAA). The direction of transcription of the early region genes, and the two unique cloningsites for cDNA insertion, are indicated. specific for the mutated site . DNA fragments containing 5' sequences of one class II isotype were ligated to those coding for 3' segments of the other isotype in the Bluescript vector. The resulting chimeric /3 chain cDNAs were then excised with Cla I and Xho I and cloned into the replicating expression vector. The authenticity of all constructs used for transfection was verified by restriction endonuclease digestion and DNA sequencing ofthe chimeric boundaries .
The chimera at amino acid 59 was constructed using the unique Sca I site common to all human class 11 0 chain DNA sequences . Recombinant plasmids containing the wild-type DR or DP (3 chain cDNA in the Bluescript vector were digested with Sca I and Cla I to generate three fragments : a Cla I to Sca I fragment consisting of 5' cDNA sequences, a Sca I to Sca I fragment containing 3' cDNA sequences and vector sequences including one half of the ampicillin resistance gene, and an Sca I to Cla I fragment containing the remainder of the amp`gene . The fragments were separated using low melting point agarose and the appro- Position of mutations created in class II cDNAs. A schematic diagram of a human class II (3 chain is shown. The positions of the signal peptide (sig), 01 domain, 02 domain, connecting peptide (cp), transmembrane region (tm), and intra-cytoplasmic portion (cyt) are shown. HVl, -2, and -3 refer to the hypervariable regions of allelic diversity. The location of the single N-linked oligosaccharide is indicated by a diamond . The numbers 1, 2, and 4 refer to the positions of unique restriction endonuclease sites that were created by site-directed mutagenesis . Site 3 is the conserved Sca I site present in DR and DP R chain cDNA sequences . These four sites form the junctions for the chimeric cDNA molecules constructed between the DR and DP (3 chain sequences . Location of the unique restriction endonuclease site generated by site-directed mutagenesis, as shown in 
Site`Enzyme
Recognition sequence Isotypel Original sequences Mutated sequences)
Avr II CCTAGG DP CCT AGG CCT AGG DR CCT AAG CCT AGG P K -R priate DNA segments religated to generate the DR:DP and DP:DR chimeras. The chimeric cDNAs were put into the expression vector and the sequences verified as above .
The nomenclature of the chimeric f3 chains is as follows . The relative order of the two isotypes involved and the position of the first amino acid in the endonuclease recognition sequence is given (using the DRl 13 chain numbering in reference 27). For example, RP22 is a 0 chain with an NH2 terminus derived from DRl and a COOH terminus derived from DP2, which is chimeric at the Eco 47 III site in the cDNA coding for amino acid 22 .
Transient Transfections. The ability of chimeric class II f chains to pair with either DR or DP a chains was tested by transfecting their cDNA into fibroblasts stably expressing the a chain (above). 5 x 105 cells were plated in each T-25 tissue culture flask on the day before transfection . The next day, 5 jig ofsupercoiled plasmid DNA was diluted with 0.5 ml ofserumfree DME for each flask. This was mixed with an equal volume of serum-free DME containing 1 mg/ml ofDEAE-dextran (Pharmacia Fine Chemicals, Piscataway, NJ) and 100 pM chloroquine diphosphonate (Sigma Chemical Co., St. Louis, MO) . The cells were washed twice with serum-free medium, and the DNA-containing solution (1 ml) was added to the cell monolayer. The cells were incubated with occasional rocking for 3 h in a humidified 37°C incubator. The DNA solution was then removed from the cells and replaced with complete medium for 24 h, then changed to complete medium supplemented with 10 mM sodium butyrate (Sigma Chemical Co.).
48 h after transfection, the cells were collected with trypsin/EDTA and incubated with saturating amounts of various mAbs on ice for 30 min. The cells were then washed and stained with fluoresceinated goat anti-mouse Ig. After the final wash, the cells were suspended in PBS containing 20 ug/ml propidium iodide (Calbiochem-Behring Corp., LaJolla, CA) . Cells were analyzed on the FACScan flow cytometer (Becton Dickinson & Co., Mountain View, CA) . A minimum of 104 live cells were analyzed.
Metabolic Labeling. Cells that had been transiently transfected with cDNAs for wild-type or chimeric class 110 chains were methionine starved by a 1-h incubation in methionine-free MEM supplemented with 10% dialyzed heat-inactivated FCS. This medium was then replaced by medium containing 0.25 mCi of "S-methionine/ml (1 Ci = 3.67 x 10'°Bq) . After 6 h at 37°, the cells were collected and washed extensively. They were then lysed in a buffer containing 0.5% NP-40, 0.15 M NaCl, 50 mM Tris/HCI, pH 7.5, 10 mM EDTA, 10 mM iodoacetamide, 10 MM t.-methionine, and 1 mM PMSE After 15 min on ice, the nuclei were spun out and the lysates precleared overnight at 4°C with I% (vol/vol) normal rabbit or mouse serum and 10% (vol/vol) preswollen protein A-agarose . After microcentrifugation, the lysates were cleared a second time with 1 :20 vol protein A-agarose. The cleared lysates were then immunoprecipitated with a combination of 1:20 vol ofmAb and 1:20 volume of protein Aagarose for 2 h at 4°C . The precipitates were washed twice with lysis buffer made 0.5 M with NaCl, twice with lysis buffer made 0.25 M with NaCl, and once with lysis buffer alone. The pellets were solubilized by heating in 2% SDS and subjected to electrophoresis in 12% polyacrylamide gels under nonreducing conditions (29) . The gels were fixed, soaked in En3Hance (Dupont-New England Nuclear, Pittsburgh, PA), dried, and exposed to Kodak X-omat film at -70°. The Mr was determined using '4C-methylated protein molecular weight standards (Amersham Corp., Arlington Heights, IL).
Results
Expression ofHuman Class II cDNAs in a Polyoma-based Replicating Vector. To rapidly analyze wild-type and mutant class II molecules, the vector R3CPy-II was constructed (Fig. 1) . This vector contains sequences for bacterial replication and ampicillin resistance from pBR322, the RSV LTR to direct expression ofinserted cDNAs, SV40 termination sequences, and the entire polyoma virus early region. Full-length, expressible cDNAs for the class II a and a chains were cloned into this vector. Murine fibroblasts were transfected with these recombinant plasmids and analyzed by flow microcytofluorimetry 48 h later. Initially, L cells were transfected with replicating plasmids for both the class II a and 0 chains simultaneously (not shown). However, it was determined that higher levels of class II expression could be obtained if either the a or,3 chain was stably transfected and the partner chain transiently transfected . Using this technique, 30-50% of the cells express class II molecules on the cell surface (see below) .
Expression ofMatched, but not Mixed Isotopic Class II Molecules. L cells that had been stably transfected with either the DR or DP a chain were then transiently transfected with the DR and DP ,8 chains encoded by the polyoma-based vector (Fig .  3) . Only the matched isotypic pairs (DRa/DRO and DP&DPO ; Fig. 3 , A and D, respectively) are expressed at the cell surface as detected by the antibody SG465, which reacts with all native class II molecules (19) . The mixed isotypic pairs (DRa/DP# and DPot/DRfl; Fig. 3 , B and C, respectively) were not detected . These transfectants were also stained with L243 (anti-HLA-DR), 137-21 (anti-HLA-DP), and SG171 and SG520 (both anti-class II (3 chain) . In all cases, only transfections of matched isotypic pairs were detected by these antibodies (not shown) . In addition, transfections of the HLA-DQ a and a chain cDNAs along with DR or DP subunit cDNAs did not result in detectable cell surface class II expression, whereas the DQa/DQ3 combination was easily detected with SG465 (not shown) .
Intracellular Pairing ofMixed Isotopic Class 11 Molecules Is Inefficient. It was possible that mixed isotypic pairs were being formed, but that they were either not being transported to the cell surface, or that the antibody SG465 required the presence of a conformational determinant present only on normal pairs. To investigate these possibilities, cells stably expressing the DR or DP a chains were transfected with either the DR or DP (3 chain cDNAs, and class II proteins were biosynthetically radiolabeled with 35S-methionine, detergent solubilized, and immunoprecipitated with rabbit antisera directed to distinct COOH-terminal ,f3 chain protein sequences. The immunoprecipitates were then analyzed by nonreducing SDS-PAGE . As shown in Fig. 4 , a significant amount of either the DR or DP ,6 chain is synthesized in all cells transiently transfected with replicating expression vectors (Fig . 4, lanes C-F) . However, only in the cells containing the homologous isotopic pairs DRa/DRf (Fig.   4 , lane C) or DP&DPO (Fig . 4, lane F) does a significant amount of the a chain coprecipitate with the a chain. As shown in Fig. 4 , lane A, the murine class II-associated invariant chain migrates just below the a chain in this electrophoretic system . It is intensely labeled due to a high methionine content. The invariant chain is only associated with paired a/fl dimers . It is not coprecipitated with either the a chain (Fig . 4, lane B) or (3 chain alone (Fig . 4, lanes D and E) . The band migrating ahead of the invariant chain corresponds to the expected position of p25, a proteolytic fragment of the invariant chain (30) .
Expression of Chimeric DRIDP,8 Chains with DR and DP a Chains . To ascertain the important a chain sequences necessary for pairing with the matched a chain, chimeric a chain cDNAs were constructed. These constructs created a chains that had both DR and DP sequences. The positions of the crossover from one isotypic sequence to the other is shown in Fig. 2 . In cases where the mutation needed to create the unique restriction site for chimera construction caused an amino acid change, an additional construct was made containing only that mutation within the wild-type DR or DP sequence . This a chain was tested along with the chimeras for association with both DR and DP a chains . 
STRUCTURAL REQUIREMENTS FOR CLASS II al(3 CHAIN PAIRING
and be expressed at the cell surface (as judged by staining with SG465) only with the DR a chain. Conversely, a a chain having DP 01 and DR 02 sequences (PR97) would only pair with the DP a chain, although the level of expression per cell was lower than that seen in the DRa/RP970 combination. Thus, the presence of isotypically matched /31 sequences alone was sufficient to allow pairing. The results of transfection of /3 chain cDNAs chimeric between DR and DP sequences at amino acids 22, 43, and 59 into DR and DP a chain-containing cells are summarized in Table II . Staining the cell surface with an anti-human class II reagent demonstrated that the DR a chain would pair and be expressed with /3 chains having DR sequence up to amino acid 22, as well as chimeras having DP sequence in their NH2 termini up to positions 43 and 59 . In addition to pairing with the PR97 a chain, the DP a chain was able to pair and express with the PR43 and PR59 (3 chains (which also paired with DRa) . The PR22, RP43, and RP59 /3 chains were unable to pair and express with either the DR or DP a chain, as judged by cell surface staining with anti-DR (L243), anti-DP (B7-21), or anti-a chain (SG171 and SG570) mAb (data not shown) .
Metabolic Labeling ofHuman Class II Molecules Containing Chimeric (DRIDP),!I Chains. As before, the apparent lack of expression of certain chimeric /3 chains with DR or DP a chains could be explained simply by either a lack of the appropriate mAb epitope, or by lack of surface expression of intracellular a/(3 dimers . To address both of these issues, cells stably expressing the DR or DP a chains were transfected with wild-type or chimeric (3 chains, labeled with 35 S-methionine, and lysed, and the lysates were immunoprecipitated with rabbit anti-COOH-terminal sera as above. The immunoprecipitates were separated on nonreducing polyacrylamide gels (Fig. 6) . RP22  40  14  0  -RP43  0  -0  -RP59  0  -0  -RP97  54  13  0  -PR22  0  -0  -PR43  41  35  55  73  PR59  48  4  29  29  PR97 0 -22 3 The surface staining of cells with the antibody SG465 correlated with the presence of significant intracellular pairing of the a and (3 chains . Those combinations that were not detected at the cell surface resulted in little or no a chain coprecipitated with the /3 chain. Therefore, the lack of expression is due to poor initial a/O pairing, rather than a defect in transport of intracellular dimers to the cell surface, or a lack of antibody binding.
With one exception, the biosynthetically labeled (3 chain chimeras migrate as poorly defined bands of heterogeneous mobility. The PR97 /3 chain migrates as a distinct doublet. The variation in the pattern of (3 chain migration from one chimera to another is highly reproducible (Fig . 6, A and B) . It is not known whether this variability in mobility represents differences in intra-chain disulfide bond formation, differences in post-translational processing, or merely the effect of different amino acid compositions .
Discussion
At present, the exact nature of the structure of class II molecules is unknown. The three-dimensional structure can be inferred by comparison to a class I molecule for which a crystal structure has been obtained (31) . The alignment of sequences and preservation of amino acid residues essential for tertiary structure (e .g., disulfide bonds and salt bridges) provides presumptive evidence for the schematized structure shown in Fig. 7 . Such modeling alone cannot predict whether there will be isotypic differences in the exact three-dimensional structure of class II, nor whether the lack of mixed isotypic pair expression at the cell surface is due to intrinsic incompatibilities between the a and /3 chains of different isotypes .
The experiments described in this report were designed to answer some of these questions. Specifically, whether mixed isotypic pairs of human class II molecules form intracellularly, whether they are expressed at the cell surface, and which parts of the class 11 0 chains are important for the ability to pair with a chains . To address these questions efficiently, a polyoma-based transient transfection system was developed . The expression vector uses the RSV LTR as a promoter for the inserted cDNA . This promoter has been shown to be very active in a variety of eukaryotic cells (32) . In particular, it has been used previously in stable transfections of L cells with human The numbers indicate the approximate positions of the sites used to create chimeric class 11 0 chains between DR and DP sequences. Amino acid 22 is in the region between the first two 0 strands, 43 is between the third and fourth 0 strands, 59 is in the beginning of the a helix, and 97 is at the beginning of the 02 domain . The parentheses mark the region of the 0 chain where the DP sequence has a twoamino acid deletion compared with DR (ADP).
class II a and 0 chains (25) . The polyoma virus early region in the vector, R3CPy-11, contains the polyoma origin of replication as well as genomic sequences for the three early proteins, large, middle, and small T antigens . Large T antigen is necessary for viral (and vector) replication and is responsible for immortalization of cells (33) . Middle T antigen is necessary for the induction of the transformed phenotype (34) . Small T antigen serves to enhance the level of viral replication (35) . Although the presence of middle and small T antigens is not absolutely necessary for polyoma replication, they were included in the expression vector in an attempt to maximize the potential amount of class 11 mRNA present in the cell . A similar vector containing the polyoma virus early region was previously used for expression of genomic clones encoding Ig H chains (36) .
In our transient system, all three isotypes of human class II can be individually expressed at the surface of murine fibroblasts . They form the appropriate heterodimers intracellularly, and bind to the murine invariant chain during biosynthesis . They each retain reactivity for specific and broadly reactive anti-class 11 mAbs . Thus, these class II molecules appear to be identical to the class 11 molecules synthesized in human APC. The demonstration of inefficient mixed isotypic pairing is unlikely to be due to the experimental system, even though minor species-or tissue-specific differences in post-translational modifications, such as carbohydrate processing, cannot be ruled out . Expression of a mixed isotypic pair, such as DRa/DQß, probably requires high intracellular levels of these chains, together with the availability of a chain present in excess over its isotypic partner (10) . Such mixed isotypic molecules are probably rare and are unlikely to contribute functionally to class II antigen diversity.
The lack of expression of mixed isotypic molecules in the transient transfection system made it possible to test which regions of class 110 chains were important for pairing with a chains . A series of chimeric 0 chains was constructed between DR and DP 0 chain sequences. The expression pattern of these chimeras with the DR or DP a chains leads to two immediate conclusions. First, that HLA-DR and HLA-DP are structurally different insofar as their requirements for cdo pairing. For example, the chimeric 0 chain RP22, having only the first 22 amino acids of the DR 0 chain sequence, is sufficient to pair with the DR a chain. The PR22 0 chain does not pair with the DP a chain. The DP a chain will pair efficiently with a chimeric 0 chain having DP sequences for the first 43 amino acids (PR43) . The converse S chain chimera, RP43, does not pair with the DR a chain. Similar results are found with R chain chimeras centered around amino acid 59 .
The second conclusion is that since the pairing of a and 0 chains of different isotypes cannot be accounted for simply on the basis of primary sequence, then secondary and tertiary structural considerations must play an important role . The model of the class II antigen-binding site developed by Brown et al . (31) (Fig . 7) can serve as a useful model for the interpretation of the data in this report . The pairing of the RP22 (3 chain with the DR a chain implies an interaction between the two /3 strands in the center of the floor of the antigen-binding site . In the case of the DP (3 chain, additional (3 sheet structure (amino acids 1-43) is needed to pair efficiently with the DP a chain. The pairing of the PR43 and PR59 a chains with both the DR and DP a chains, and the lack of pairing of the RP43 and RP59 (3 chains with either a chain, have several possible explanations . First, there is a two-amino acid deletion in the DP (3 chain sequence relative to the DR sequence just after amino acid 22 . Although the DR and DP a chains are of identical length, the tertiary structure of the DP a chain may have evolved to compensate for this deletion . In addition, the pairing pattern of these chimeras may demonstrate the effects of different regions of a//3 interaction . The failure of RP43 and RP59 /3 chains to assemble with a chains may reflect specific interactions between the a helix and the underlying /3 strands in DP /3 chains . Further, the pairing of the PR43 and PR59 (3 chains with the DR a chain may imply that there is significant interaction between the a-helical portions of the 01 domain (amino acids 59-97) of DR and portions of the DR a chain. Studies with a chain chimeras will provide additional insight on this point. A different structure for the DR and DP NH2-terminal domains would have important implications in class II antigen function . For example, the nature of immunogenic peptides that bind to DP may be different than those that bind to DR . In this way, different isotypes of class II would serve to broaden the immune response of an individual by presenting a wider array of antigens . In addition, there may be differences in the way class II molecules interact with the TCR, or with coreceptor molecules such as CD4. Finally, there have been several recent reports that bacterial toxins that serve as "super antigens," activating T cells in vitro, bind directly to class II molecules (37, 38) . There is a definite hierarchy of binding to different class II isotypes among the various toxins tested . The molecular basis for these differences should be readily testable using class II molecules with chimeric and point-mutated a and a chains .
Summary
To test for the assembly of human MHC class II molecules having an a chain from one isotype (HLA-DR, -DQ, or -DP) and the (3 chain of another (mixed isotypic pairs), murine fibroblasts were transfected with expressible cDNAs encoding the different class II a and /3 chains . A rapid and efficient transient transfection system was developed using a polyoma virus-based vector. Typically, 30-50% of cells transfected using this system expressed high levels of class II molecules on their surface, but only with matched isotypic pairs. Biochemical analysis of cells transfected with matched or mixed isotypic pairs of the DR and DP molecules revealed that only matched chains could pair efficiently inside the cell . Thus, the lack of expression of the two mixed isotypic pairs is due to inefficient primary assembly of the class II molecule and not to a processing or transport defect .
To define what region of the (3 chains controlled their assembly with a chains, a series ofchimeric cDNA molecules containing both DR and DP 0 chain sequences were constructed . Expression of these chimeric a chains with DR and DP a chains was determined by cytofluorimetry and biochemical analysis . Both a chains paired with (3 chains in which only the 01 domain was isotypically matched . In contrast, the pattern of expression of chimeras made at other points within the /31 domain was different for DR and DP These data show that different areas of primary sequence are important for the assembly ofdifferent human class 11 isotypes, and suggest that HLA-DR and -DP molecules have different secondary or tertiary structures in their NH2-terminal domains .
